A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain
Clinical trial NCT03877718 · COMPLETED
Trial details
- NCT number
- NCT03877718
- Sponsor
- Charleston Laboratories, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-01
- Primary completion
- 2019-08-27
- Enrollment
- 475
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.